Άρθρα - Μελέτες - Page 4 of 13 - Endocrinutri - Ενδοκρινολόγος – Διαβητολόγος Κωνσταντίνος Μπουτσούρης

Treatment of thyroid disorders before conception and in early pregnancy: a systematic review; Vissenberg R, van den Boogaard E, van Wely M, van der Post JA, Fliers E, Bisschop PH, Goddijn M; Human Reproduction Update (Mar 2012)

endocrinutri2020-01-29T13:32:06+00:00

BACKGROUNDThyroid disorders are associated with pregnancy complications. Universal screening is [...]

Treatment of thyroid disorders before conception and in early pregnancy: a systematic review; Vissenberg R, van den Boogaard E, van Wely M, van der Post JA, Fliers E, Bisschop PH, Goddijn M; Human Reproduction Update (Mar 2012)endocrinutri2020-01-29T13:32:06+00:00

Levothyroxine Treatment of Subclinical Hypothyroidism, Fatal and Nonfatal Cardiovascular Events, and Mortality; Razvi S, Weaver JU, Butler TJ, Pearce SH; Archives of Internal Medicine (Apr 2012)

endocrinutri2020-01-29T13:31:26+00:00

BACKGROUND: Subclinical hypothyroidism (SCH) has been associated with ischemic heart [...]

Levothyroxine Treatment of Subclinical Hypothyroidism, Fatal and Nonfatal Cardiovascular Events, and Mortality; Razvi S, Weaver JU, Butler TJ, Pearce SH; Archives of Internal Medicine (Apr 2012)endocrinutri2020-01-29T13:31:26+00:00

Pituitary tumorous hyperplasia due to primary hypothyroidism; Han L, Wang J, Shu K, Lei T; Acta Neurochirurgica (Apr 2012)

endocrinutri2020-01-29T13:30:50+00:00

BACKGROUND: To study the diagnostic and therapeutic features of pituitary [...]

Pituitary tumorous hyperplasia due to primary hypothyroidism; Han L, Wang J, Shu K, Lei T; Acta Neurochirurgica (Apr 2012)endocrinutri2020-01-29T13:30:50+00:00

Subclinical Hyperthyroidism and the Risk of Coronary Heart Disease and Mortality; Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P, Iervasi G, Asvold BO, Sgarbi JA, Völzke H, Gencer B, Maciel RM, Molinaro S, Bremner A, Luben RN, M

endocrinutri2020-01-29T13:30:18+00:00

BACKGROUND: Data from prospective cohort studies regarding the association between [...]

Subclinical Hyperthyroidism and the Risk of Coronary Heart Disease and Mortality; Collet TH, Gussekloo J, Bauer DC, den Elzen WP, Cappola AR, Balmer P, Iervasi G, Asvold BO, Sgarbi JA, Völzke H, Gencer B, Maciel RM, Molinaro S, Bremner A, Luben RN, Mendocrinutri2020-01-29T13:30:18+00:00

Role of RANK Ligand and Denosumab, a Targeted RANK Ligand Inhibitor, in Bone Health and Osteoporosis: A Review of Preclinical and Clinical Data; Dempster DW, Lambing CL, Kostenuik PJ, Grauer A; Clinical Therapeutics 34 (3), 521-536 (Mar 2012)

endocrinutri2020-01-29T13:29:39+00:00

BACKGROUND: Postmenopausal osteoporosis results from bone loss and decreased bone [...]

Role of RANK Ligand and Denosumab, a Targeted RANK Ligand Inhibitor, in Bone Health and Osteoporosis: A Review of Preclinical and Clinical Data; Dempster DW, Lambing CL, Kostenuik PJ, Grauer A; Clinical Therapeutics 34 (3), 521-536 (Mar 2012)endocrinutri2020-01-29T13:29:39+00:00

The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention: An intent-to-treat analysis of the DPP/DPPOS; The Diabetes Prevention Program Research Group; Diabetes Care 35 (4), 723-730 (Apr 2012)

endocrinutri2020-01-29T13:29:00+00:00

OBJECTIVE The Diabetes Prevention Program (DPP) and its Outcomes Study [...]

The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention: An intent-to-treat analysis of the DPP/DPPOS; The Diabetes Prevention Program Research Group; Diabetes Care 35 (4), 723-730 (Apr 2012)endocrinutri2020-01-29T13:29:00+00:00

Thyroid disorders during pregnancy; Yazbeck CF, Sullivan SD; Medical Clinics of North America 96 (2), 235-56 (Mar 2012) Tags: levothyroxine sodium Pregnancy Thyroid Disorders

endocrinutri2020-01-29T13:28:01+00:00

Thyroid disorders are common in women during pregnancy. If left [...]

Thyroid disorders during pregnancy; Yazbeck CF, Sullivan SD; Medical Clinics of North America 96 (2), 235-56 (Mar 2012) Tags: levothyroxine sodium Pregnancy Thyroid Disordersendocrinutri2020-01-29T13:28:01+00:00

Dipeptidyl Peptidase-4 Inhibitors in the Elderly: More Benefits or Risks?; Paolisso G, Monami M, Marfella R, Rizzo MR, Mannucci E; Advances in Therapy (Mar 2012)

endocrinutri2020-01-29T13:26:35+00:00

Several studies have shown a high prevalence of type 2 [...]

Dipeptidyl Peptidase-4 Inhibitors in the Elderly: More Benefits or Risks?; Paolisso G, Monami M, Marfella R, Rizzo MR, Mannucci E; Advances in Therapy (Mar 2012)endocrinutri2020-01-29T13:26:35+00:00

Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer; Sadeghi N, Abbruzzese JL, Yeung SC, Hassan M, Li D; Clinical Cancer Research (Mar 2012)

endocrinutri2020-01-29T13:25:25+00:00

PURPOSE: Accumulating evidence suggests that metformin has antitumor activity. The [...]

Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer; Sadeghi N, Abbruzzese JL, Yeung SC, Hassan M, Li D; Clinical Cancer Research (Mar 2012)endocrinutri2020-01-29T13:25:25+00:00

Review: DPP-4 inhibitors are less effective than metformin for reducing HbA1c in type 2 diabetes; Chatterjee S; Annals of Internal Medicine 157 (2), JC1-13 (Jul 2012

endocrinutri2020-01-29T13:23:51+00:00

QUESTION In adults with type 2 diabetes mellitus, are dipeptidyl [...]

Review: DPP-4 inhibitors are less effective than metformin for reducing HbA1c in type 2 diabetes; Chatterjee S; Annals of Internal Medicine 157 (2), JC1-13 (Jul 2012endocrinutri2020-01-29T13:23:51+00:00